Scholarlink

Background <p>In recent years, telerehabilitation (TR) has been more widely applied in the management of Parkinson’s disease (PD), but the therapeutic effect is unclear. This systematic review intended to examine the efficacy of TR in improving rehabilitation outcomes in PD.</p> Methods <p>We retrieved data from PubMed, Embase, Cochrane Library, Web of Science, SinoMed, China National Knowledge Infrastructure (CNKI), and VIP Database, from database inception to 22 April 2025. Search terms included “Parkinson Disease” and “Telerehabilitation”. Outcome measures included PDQ-39 and MDS-UPDRS III. The pooled effect size in this study was expressed as mean difference (MD) values. Analysis was done on R 4.4.1, and study quality was assessed with Cochrane RoB2.</p> Results <p>A total of ten studies were included, encompassing 683 patients. Among them, 344 patients were in the TR treatment group and 339 were in the control group. Analysis revealed that compared to control groups, TR significantly ameliorated motor function and quality of life (QoL) in PD patients, including UPDRS III (WMD − 4.11, 95%CI -8.09, -0.13, <i>p</i> = 0.043), PDQ39 (WMD − 7.07, 95% CI -11.27, -2.86, <i>p</i> &lt; 0.01).</p> Conclusion <p>According to the analysis results, TR displayed significant efficacy in improving the motor function and QoL of PD patients. It provides a possible and effective teletherapy for the rehabilitation of PD. Besides, TR can take place in the home setting, which is acceptable and practical. Therefore, it has the potential to be widely used in the future management of PD.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Telerehabilitation for Parkinson’s disease: a systematic review and meta-analysis based on randomized controlled trials

  • 期刊论文

  • 发表日期：

    2025年12月19日

查看全文
  • Renfei Li,
  • Lili Wang,
  • Jian Zhang

摘要

Background

In recent years, telerehabilitation (TR) has been more widely applied in the management of Parkinson’s disease (PD), but the therapeutic effect is unclear. This systematic review intended to examine the efficacy of TR in improving rehabilitation outcomes in PD.

Methods

We retrieved data from PubMed, Embase, Cochrane Library, Web of Science, SinoMed, China National Knowledge Infrastructure (CNKI), and VIP Database, from database inception to 22 April 2025. Search terms included “Parkinson Disease” and “Telerehabilitation”. Outcome measures included PDQ-39 and MDS-UPDRS III. The pooled effect size in this study was expressed as mean difference (MD) values. Analysis was done on R 4.4.1, and study quality was assessed with Cochrane RoB2.

Results

A total of ten studies were included, encompassing 683 patients. Among them, 344 patients were in the TR treatment group and 339 were in the control group. Analysis revealed that compared to control groups, TR significantly ameliorated motor function and quality of life (QoL) in PD patients, including UPDRS III (WMD − 4.11, 95%CI -8.09, -0.13, p = 0.043), PDQ39 (WMD − 7.07, 95% CI -11.27, -2.86, p < 0.01).

Conclusion

According to the analysis results, TR displayed significant efficacy in improving the motor function and QoL of PD patients. It provides a possible and effective teletherapy for the rehabilitation of PD. Besides, TR can take place in the home setting, which is acceptable and practical. Therefore, it has the potential to be widely used in the future management of PD.